Recent News

Continuous Surgical Staple Recalls Lead to Increased Litigation

For many years, defective surgical staples have caused irreparable harm to patients, but these dangers remained hidden. In 2019, the Food and Drug Administration (FDA) acknowledged that thousands of surgical staple malfunction reports were hidden from the public. Here, the medical device litigation team at Peter Angelos, P.C. discusses the various companies under scrutiny for…

Read More...

FDA Requests Removal of Zantac From the Market Immediately

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of possible carcinogenic effects of the contaminant N-nitrosodimethylamine, or NDMA. Here, the pharmaceutical liability attorneys at Peter Angelos, P.C. discuss…

Read More...

Singulair – FDA Strengthens Warning of Serious Mood and Behavorial Side Effects, Including Suicidal Thoughts, Associated with Common Allergy Medications

After convening a panel of outside experts, the FDA determined that the asthma and allergy medication montelukast, available as brand-name Singulair or in generic form, should include a Boxed Warning to ensure that health care professionals and patients are aware of the potential for severe mood-related side effects, particularly in children. Here, the skilled pharmaceutical…

Read More...

FDA Requests Withdrawal of Weight-Loss Drug

On February 13th, the Food and Drug Administration (FDA) requested that drug manufacturer Eisai Inc. remove diet drugs Belviq and Belviq XR from the market after a clinical trial showed an increased occurrence of cancer in patients taking Belviq. Here, the pharmaceutical liability attorneys at Peter Angelos, P.C. discuss the FDA’s decision to request this…

Read More...

The FDA Issues Warning Letter to Vivitrol Manufacturer Alkermes for Omitting Risk Information

In December 2019, the Food and Drug Administration (FDA) sent a warning letter to Alkermes, the manufacturers of the drug Vivitrol, for a print advertisement that misled consumers by omitting important risk information. By failing to admit the potentially fatal consequences of opioid intoxication, the safety of Vivitrol is now being called into question. Here,…

Read More...

The FDA Requests Allergan Voluntarily Recall

In August 2019, the Food and Drug Administration (FDA) requested that Allergan recall its BIOCELL textured breast implants and tissue expanders due to an increased risk of cancer among implant patients. Here, the product and medical device  liability litigation attorneys at Peter Angelos P.C. discuss the connection between Allergan’s BIOCELL products and the increased risk…

Read More...

Continuation of Monsanto Dicamba Litigation Updates

In August 2019, environmentally conscious public-interest organizations filed a lawsuit against the U.S. Environmental Protection Agency and agrochemical company, Monsanto, after the approval of a pesticide meant for use on soybean and cotton plants. Here, the environmental litigation attorneys at Peter Angelos P.C. discuss the controversy surrounding the damaging dicamba pesticide and how the EPA’s…

Read More...

Updates on Studies Concerning Link Between Breast Cancer and Implants

In July 2019, pharmaceutical manufacturer Allergan ordered a recall of its BIOCELL textured breast implants after reports that the implants were linked to a serious cancer affecting hundreds of patients. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss recent updates to this serious event as well as your legal options if you have…

Read More...

Juul Facing Litigation Concerning Death of 18-Year-Old

Amidst the growing litigation against Juul Labs, the e-cigarette powerhouse is now facing a lawsuit in regards to the death of an 18-year old Florida teenager who died after using vaping devices. Here, the attorneys at Peter Angelos, P.C. detail recent updates to ongoing Juul litigation and as well as insights to the first major…

Read More...

FDA Issues a Class I Recall of the ROSA Brain 3.0 Robotic Surgery System by Zimmer Biomet

Medical device company Zimmer Biomet recently issued a Class I recall of the ROSA Brain 3.0 Robotic Surgery System due to a major software issue that caused the device to malfunction. The malfunction could cause serious injury or even death to patients receiving neurosurgery that utilizes the device. Here, the medical product liability attorneys at…

Read More...